Back to Journals » Drug Design, Development and Therapy » Volume 13

Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways

Total article views   HTML views PDF downloads Totals
7,841 Dovepress* 6,338+ 1,010 7,348
PubMed Central* 1,503 402 1,905
Totals 7,841 1,412 9,253
*Since 2 December 2019

View citations on PubMed Central and Google Scholar